Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512).
Trotti A 3rd, Zhang Q, Bentzen SM, Emami B, Hammond ME, Jones CU, Morrison WH, Sagar SM, Ridge JA, Fu KK, Ang KK. Trotti A 3rd, et al. Among authors: fu kk. Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):958-963. doi: 10.1016/j.ijrobp.2014.04.041. Epub 2014 Jul 8. Int J Radiat Oncol Biol Phys. 2014. PMID: 25035199 Free PMC article. Clinical Trial.
Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer.
Beitler JJ, Zhang Q, Fu KK, Trotti A, Spencer SA, Jones CU, Garden AS, Shenouda G, Harris J, Ang KK. Beitler JJ, et al. Among authors: fu kk. Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):13-20. doi: 10.1016/j.ijrobp.2013.12.027. Epub 2014 Mar 7. Int J Radiat Oncol Biol Phys. 2014. PMID: 24613816 Free PMC article. Clinical Trial.
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, Garden AS, Ridge JA, Cooper JS, Ang KK. Fu KK, et al. Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):7-16. doi: 10.1016/s0360-3016(00)00663-5. Int J Radiat Oncol Biol Phys. 2000. PMID: 10924966 Clinical Trial.
Microvessel density >or=60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the Radiation Therapy Oncology Group (RTOG) 90-03 Trial.
Calvin DP, Hammond ME, Pajak TF, Trotti AM, Meredith RF, Rotman M, Jones CU, Byhardt RW, Demas WF, Ang KK, Fu KK; Radiation Therapy Oncology Group 90-03 Trial. Calvin DP, et al. Among authors: fu kk. Am J Clin Oncol. 2007 Aug;30(4):406-19. doi: 10.1097/COC.0b013e3180342fd4. Am J Clin Oncol. 2007. PMID: 17762442
Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials.
Cox JD, Scott CB, Byhardt RW, Emami B, Russell AH, Fu KK, Parliament MB, Komaki R, Gaspar LE. Cox JD, et al. Among authors: fu kk. Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):505-9. doi: 10.1016/s0360-3016(98)00429-5. Int J Radiat Oncol Biol Phys. 1999. PMID: 10078629
In response to Drs. Dubben, Beck-Bornholdt, and Llogie.
Ang KK, Berkey BA, Pajak TF, Fu KK. Ang KK, et al. Among authors: fu kk. Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):1148-50. doi: 10.1016/s0360-3016(01)02777-8. Int J Radiat Oncol Biol Phys. 2002. PMID: 11958923 No abstract available.
178 results